首页BRNS • NASDAQ
add
Barinthus Biotherapeutics PLC - ADR
财务信息
损益表
收入
净收入
| (USD) | 2024年9月info | 年同比变化 |
|---|---|---|
收入 | 1496.90万 | — |
经营支出 | 2372.50万 | 49.31% |
净收入 | -811.40万 | 42.34% |
净利润率 | -54.21 | — |
每股收益 | -0.21 | 43.24% |
息税折旧摊销前利润 | -847.50万 | 41.43% |
有效税率 | 0.04% | — |
资产负债表
总资产
负债总额
| (USD) | 2024年9月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 1.06亿 | -33.81% |
总资产 | 1.89亿 | -17.95% |
负债总额 | 2922.80万 | -14.95% |
权益总额 | 1.59亿 | — |
发行在外的股份 | 4022.85万 | — |
市净率 | 0.25 | — |
资产回报率 | -12.19% | — |
资本回报率 | -13.40% | — |
现金流
现金净变动
| (USD) | 2024年9月info | 年同比变化 |
|---|---|---|
净收入 | -811.40万 | 42.34% |
来自运营的现金 | -1819.80万 | -62.61% |
投资现金 | -11.40万 | -216.67% |
融资现金 | 46.50万 | 910.87% |
现金净变动 | -1167.20万 | 8.25% |
自由现金流 | -1825.84万 | -1,948.34% |
简介
Barinthus Biotherapeutics plc is a biotechnology company developing immunotherapies for infectious diseases, cancer and autoimmune diseases such as hepatitis B, HPV and prostate cancer. Formerly known as Vaccitech plc, in November 2023 the company announced that it had renamed itself to Barinthus Biotherapeutics plc. As of 2024, the company employs more than 100 people. Wikipedia
成立时间
2016
员工数量
130
